Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial

References

Page 1

	Year	Citations
The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis Frank C. Arnett, Steven M. Edworthy, D. Blöch, Arthritis & Rheumatism	1988	19.8K
Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis M.L.L. Prevoo, Martin A. van't Hof, H. H. Kuper, Arthritis & Rheumatism	1995	6.1K
The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment Ferdinand C. Breedveld, Michael H. Weisman, Arthur F. Kavanaugh, Arthritis & Rheumatism	2005	1.8K
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial Lars Klareskog, Désirée van der Heijde, J Jäger, The Lancet Rheumatoid DisorderRheumatologyTherapeutic EffectAutoimmune DiseaseMedicine	2004	1.8K
Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks Stanley Cohen, Paul Emery, Maria Greenwald, Arthritis & Rheumatism	2006	1.6K
The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials David T. Felson, Jennifer J. Anderson, Maarten Boers, Arthritis & Rheumatism	1993	1.6K
Development and validation of the european league against rheumatism response criteria for rheumatoid arthritis: Comparison with the preliminary american college of rheumatology and the world health organization/international league against rheumatism criteria Anke M. van Gestel, M.L.L. Prevoo, Martin A. van't Hof, Arthritis & Rheumatism	1996	1.6K
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis Kenneth G. Saag, Gim Gee Teng, Nivedita M. Patkar, Arthritis Care & Research Orthopedic Physical TherapyPharmacotherapyInflammatory ArthritisRheumatoid DisorderChronic Disease Management	2008	1.5K
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial E. William St. Clair, Désirée van der Heijde, Josef S Smolen, Arthritis & Rheumatism	2004	1.2K
The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double‐blind, placebo‐controlled, dose‐ranging trial Paul Emery, Roy Fleischmann, Anna Filipowicz‐Sosnowska, Arthritis & Rheumatism	2006	1K

Page 1